Home / Success Plan (Invoice-based) – Terms & Conditions
Success Plan (Invoice-based) – Terms & Conditions
By subscribing to the Success Plan (Invoice-based), you agree to the following plan-specific terms. These apply in addition to the MAI CDMO Legal Terms.
With the Success Plan – Invoice-based you get:
Note: This service is provided on a non-exclusive basis. Introductions do not guarantee client responses, lead volume, or awarded projects.
Each time you receive a client payment, MAI CDMO issues an invoice for the applicable commission. Payment is due within 30 days of the invoice date, by bank transfer to the account provided on the invoice.
A “Client” means any company contacted through the MAI CDMO platform or promotional activities for a defined project and regulatory requirements analyzed by MAI CDMO.
Exception: If you can prove a pre-existing commercial relationship with the same client (by providing a formal proposal sent within the last 5 years for the same activity and regulatory requirements), the client will not be considered an introduced Client for fee purposes. If no such proof is provided, the Client will be deemed introduced by MAI CDMO, and fees will apply.
The initial term of the subscription shall be one (1) year. The subscription will automatically renew for additional one (1) year terms unless either party provides written notice or, through the platform (Account settings), its intention not to renew at least three (3) months prior to the expiration date.
2026-02-12
Beyond Capacity: How Smarter Science is Redefining Biologics Manufacturing
See more
2026-02-04
What truly matters when selecting a Contract Manufacturing Organization for clinical and commercial success
See more
2026-01-30
Regulatory expertise can be the difference between a smooth veterinary drug approval and costly delays.
See more
Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
Accueil Sites Osny. Acquired in 2011, the Osny site specializes in the development and production of highly active solid pharmaceutical forms (hormonal and allergens). This 4,000 m2 pharmaceutical plant located 36 km northwest of Paris employs around a hundred people.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), NMPA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: N/A
Batch Size / Reactor: Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Your cGMP-compliant CDMO for end-to-end services in the complex oral solids dosage forms field, based in Binzen Germany
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Cell Therapy company with excess Cleanroom capacity
Activity: FDF / DRUG PRODUCTS, BIOLOGICS, SERVICES manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP)
Markets: EMA (EU)
Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.
Activity: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING manufacturing
Uses: Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Seda Pharmaceutical Development Services specialises in integrated Pharmaceutical Development and Clinical Pharmacology.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: ECOVADIS, MHRA (UK GMP)
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
If you have any questions or suggestions, click here. We will be happy to assist you.
